Literature DB >> 2689042

Effect of dietary protein on renal tubular clearance of drugs in humans.

G D Park1, R Spector, T M Kitt.   

Abstract

Diet is one of many factors that influence the pharmacokinetics of drugs. The level of protein intake has been found to significantly influence drug metabolism and glomerular filtration, both of which play an important role in the clearance of drugs. Recently, a marked change, resulting from restricted dietary protein intake, has been reported in the handling of several drugs which are reabsorbed and/or secreted by the renal tubules. In studies of healthy volunteers on protein-restricted diets the renal clearance and fractional excretion of model compounds have been altered, falling to 30% of values obtained on normal diets in the case of the weak acids oxipurinol and uric acid; the fractional excretion of the weak base cimetidine has been increased by 30%. These studies have also found that the change in the renal clearance of both acids is sustained with prolonged dietary protein-calorie restriction, and that, for oxipurinol, the magnitude of the change is directly related to the quantity of protein in the diet, the change is related specifically to the protein content in the diet (and not the total calories), the onset of change is rapid, and on a low-protein diet the renal clearance undergoes marked diurnal variation. The mechanism for the alteration in tubular function is not clear, but may be related to renal haemodynamic changes or competition for transport associated with protein intake. Regardless of the mechanism, these results have important implications for pharmacokinetic research and clinical practice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2689042     DOI: 10.2165/00003088-198917060-00006

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  27 in total

1.  RENAL RETENTION OF URIC ACID INDUCED BY INFUSION OF BETA-HYDROXYBUTYRATE AND ACETOACETATE.

Authors:  S GOLDFINGER; E KLINENBERG; J E SEEGMILLER
Journal:  N Engl J Med       Date:  1965-02-18       Impact factor: 91.245

2.  Salt and protein restriction; effects on blood pressure and renal hemodynamics in hypertensive patients.

Authors:  H CHASIS; W GOLDRING
Journal:  J Am Med Assoc       Date:  1950-03-11

3.  Renal clearances of oxypurinol and inulin on an isocaloric, low-protein diet.

Authors:  T M Kitt; G D Park; R Spector; W Lawton; E Tsalikian
Journal:  Clin Pharmacol Ther       Date:  1988-06       Impact factor: 6.875

4.  Renal clearance of oxipurinol, the chief metabolite of allopurinol.

Authors:  G B Elion; T F Yü; A B Gutman; G H Hitchings
Journal:  Am J Med       Date:  1968-07       Impact factor: 4.965

Review 5.  Human circadian rhythms.

Authors:  J N Mills
Journal:  Physiol Rev       Date:  1966-01       Impact factor: 37.312

6.  The effect of dietary protein-calorie restriction on the renal elimination of cimetidine.

Authors:  L M Gersema; G D Park; T M Kitt; R Spector
Journal:  Clin Pharmacol Ther       Date:  1987-10       Impact factor: 6.875

Review 7.  Drug disposition in children with protein energy malnutrition.

Authors:  S Mehta
Journal:  J Pediatr Gastroenterol Nutr       Date:  1983       Impact factor: 2.839

8.  The effect of dietary protein on the clearance of allopurinol and oxypurinol.

Authors:  W G Berlinger; G D Park; R Spector
Journal:  N Engl J Med       Date:  1985-09-26       Impact factor: 91.245

9.  Renal excretion of uric acid during prolonged fasting.

Authors:  I H Fox; M L Halperin; M B Goldstein; E R Marliss
Journal:  Metabolism       Date:  1976-05       Impact factor: 8.694

Review 10.  Influences of diet and nutrition on clinical pharmacokinetics.

Authors:  K E Anderson
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

View more
  4 in total

Review 1.  Genetic predisposition for multiple myeloma.

Authors:  Maroulio Pertesi; Molly Went; Markus Hansson; Kari Hemminki; Richard S Houlston; Björn Nilsson
Journal:  Leukemia       Date:  2020-01-08       Impact factor: 11.528

Review 2.  Cancer Immunoprevention: Current Status and Future Directions.

Authors:  Mahsa Keshavarz-Fathi; Nima Rezaei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-02-27       Impact factor: 4.291

3.  The effect of a protein meal on zidovudine pharmacokinetics in HIV-infected patients.

Authors:  J Sahai; K Gallicano; G Garber; I McGilveray; N Hawley-Foss; N Turgeon; D W Cameron
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

Review 4.  The hidden variables problem in Alzheimer's disease clinical trial design.

Authors:  S Imindu Liyanage; Clarissa Santos; Donald F Weaver
Journal:  Alzheimers Dement (N Y)       Date:  2018-11-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.